관련문헌 등
·Campbell's Operative Orthopaedics, 13th. edition, 2017, Chapter 33, Cerebral Palsy
·Campbell's Operative Orthopaedics, 13th. edition, 2017, Chapter 72, Cerebral Palsy of the Hand. Nonoperative Management
·Braddom's Physical Medicine and Rehabilitation, Fifth Edition, 2016, Chapter 47. Cerebral Palsy Management of Hypertonia
·Principles and Practice of Movement Disorders, Chapter 13. Treatment of dystonia; 2011
·Cummings Otolaryngology. Sixth Edition. Neurologic Disorders of the Larynx; 2015
·NICE(Published date: July 2012, Last updated: November 2016)
·PBS (Published on: March 1, 2019) BOTULINUM TOXIN TYPE A
·Aetna (2019.2.26.). Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan
·Hoare BJ et al. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE) (Review). Cochrane Database of Systematic Reviews. 2010.
·Pascual SI et al. Safety of botulinum toxin type A in children younger than 2 years. European journal of paediatric neurology 13(2009); 511-515
·Love S.C, et al. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. European journal of neurology 2010, 17(Suppl.2): 9-37
·Fehlings D et al, Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. European journal neurology 2010, 17(Suppl. 2): 38-56
·Baker JA et al. The efficacy of Botulinum Toxin A for limb spasticity on improving activity restriction and quality of life: A systematic review and meta-analysis using the GRADE approach. Clinical Rehabilitation 2015.1-10
·Placzek R et al, Development of Treatment concepts for the use of botulinum toxin A in children with cerebral palsy. Toxins 2010, 2, 2258-2271
·Heinen F et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. European journal of paediatric neurology 14(2010) 45-66
·Druschel C. et al. Off Label of Botulinum Toxin in Children under Two Years of Age: A Systematic Review. Toxins 2013, 5, 60-72
·Strobl W et al. Best Clinical Practice in Botulinum Toxin Treatment for children with Cerebral Palsy. Toxins 2015,7,1629-1648
·양윤수, 연축성 발성장애. 대한이비인후과학회지 2010;53(9): 519-526
·최홍식. 연축성 발성장애(Spasmodic Dysphonia)에 대한 보톡스 주입치료. 대한후두음성언어학회지 2012 23(2).99-103
·Watts C et al. Botulinum toxin for treating spasmodic dysphonia(laryngeal dystonia): a systematic Cochrane review. Clinical Rehabilitation 2006 Feb;20(2):112-122
·van Esch BF. et al, Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients: A Systematic Review. Ptolaryngology-Head and Neck Surgery 2017,Vol. 156(2) 238-254